J. Coghlan

Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

A. Wells, C. Denton, B. Schreiber, 2014, Arthritis & rheumatology.

Combined Pulmonary Fibrosis and Emphysema in Scleroderma‐Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension

A. Nicholson, D. Hansell, C. Denton, 2016, Arthritis & rheumatology.

Safety and feasibility audit of a home-based drug-transitioning approach for patients with pulmonary arterial hypertension: an observational study

B. Schreiber, J. Coghlan, J. Coghlan, 2018, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma.

N. McHugh, J. Easaw, J. Pauling, 2008, Rheumatology.

Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension.

A. Holmes, C. Black, J. Coghlan, 2003, Respiratory medicine.

The myth of pulmonary Raynaud’s phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension

C. Denton, C. Black, V. Ong, 2004, Annals of the rheumatic diseases.

Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2

M. Humbert, H. Ghofrani, F. Grimminger, 2016, Annals of the rheumatic diseases.

Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.

C. Denton, C. Black, A. Wells, 2010, QJM : monthly journal of the Association of Physicians.